ONMD

ONMD OneMedNet Corporation

Stock · NasdaqCM · United States · Healthcare · US68270C2026

NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by OneMedNet Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.

Price 5.14 USD +23.26%

52-week range 3.61 – 23.00

Dividend yield—

Market cap29.9M

NowoTrade score 3 Grade B

Price history

Daily prices in USD.

Updated 08 Nov 2026 14:36. Information, not advice.

Results

Next results —No date announced yet

Last results —Nothing reported yet

Beat the estimate —

Average surprise — reported against the estimate, last 0 quarters

Annual results · USD

Year	Revenue	Change	Net income	Net margin	EPS	EPS change	Free cash flow
2025	1.4M	+111.4%	-2.8M	-206.1%	-0.06	+83.3%	-7.5M
2024	643K	-37.0%	-10.1M	-1,575.3%	-0.36	+92.3%	-7M
2023	1M	-11.4%	-33.8M	-3,308.5%	-4.65	+38.4%	-4.8M
2022	1.2M	—	-30.5M	-2,641.0%	-7.55	—	-4.8M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Day Week Month

Price history in USD, by day
Period	Opening price	High	Low	Closing price	Change	Volume
22 Jan 2026	9.21	9.69	8.90	9.67	+12.05%	48,130
21 Jan 2026	9.30	9.31	8.51	8.63	-7.30%	27,250
20 Jan 2026	9.00	9.54	8.50	9.31	+3.44%	40,500
16 Jan 2026	9.35	10.30	9.00	9.00	+5.88%	52,780
15 Jan 2026	10.80	10.90	8.15	8.50	-22.73%	97,770
14 Jan 2026	11.00	11.10	10.50	11.00	+2.80%	38,960
13 Jan 2026	11.70	11.70	10.60	10.70	-9.32%	60,970
12 Jan 2026	11.10	12.10	11.10	11.80	+4.42%	29,450
09 Jan 2026	12.00	12.00	11.20	11.30	-5.04%	24,950
08 Jan 2026	11.70	12.19	11.50	11.90	+1.71%	19,230
07 Jan 2026	11.80	12.15	11.60	11.70	-3.31%	29,380
06 Jan 2026	11.90	12.30	11.60	12.10	0.00%	19,130
05 Jan 2026	12.20	12.79	11.60	12.10	-0.82%	34,420
02 Jan 2026	11.20	12.40	11.20	12.20	+10.91%	35,680
31 Dec 2025	10.70	12.39	10.50	11.00	+4.76%	45,290
30 Dec 2025	11.50	12.14	10.40	10.50	-10.26%	101,960
29 Dec 2025	12.30	13.00	11.68	11.70	-7.87%	30,100
26 Dec 2025	13.40	13.48	12.40	12.70	-4.51%	50,740
24 Dec 2025	12.90	14.30	12.90	13.30	+3.10%	53,750
23 Dec 2025	14.00	14.18	12.40	12.90	-7.86%	32,880
22 Dec 2025	13.50	15.39	13.46	14.00	+6.87%	67,800
19 Dec 2025	12.40	13.60	12.20	13.10	+6.50%	26,380
18 Dec 2025	13.10	14.00	12.00	12.30	-6.11%	42,580
17 Dec 2025	13.90	14.10	12.40	13.10	-7.09%	34,300
16 Dec 2025	12.30	14.40	12.30	14.10	+13.71%	56,510

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook (opens in a new tab) 06 Nov 2026 13:30
OneMedNet Reports QQ3 Preliminary Revenue Of ~$1M, Up 465% YoY; Anticipates Q4 Revenue Range $12M - $14M (opens in a new tab) Benzinga · 06 Nov 2026 09:34
OneMedNet Receives Mid Six-Figure Re-Order from Foundation Model Company Developing Radiology Models (opens in a new tab) 04 Nov 2026 13:45
OneMedNet Receives Six-Figure Reorder From Undisclosed Foundation Model Firm Developing AI Models For Radiology (opens in a new tab) Benzinga · 04 Nov 2026 09:46
OneMedNet Receives High Six-Figure Add-On Order Under Multiyear Agreement Announced September 30 (opens in a new tab) 03 Nov 2026 13:40

Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close: 4.17 USD
Market cap: 29.9M
Exchange: NasdaqCM
Country: United States
Sector: Healthcare
Industry: Health Information Services
Currency: USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the score	Points	Why
Business growth Yearly growth of revenue and of earnings per share.	9.4 / 25	Revenue growth of 5.6% a year
Quality Return on equity, net margin and how stable the margins are.	0.0 / 25	—
Financial strength Net debt against operating earnings, interest cover and free cash flow.	0.0 / 20	Free cash flow yield of -14.1%
Valuation Free cash flow yield and the P/E against its sector.	0.0 / 15	Price / sales 20.6: it has no profit to price yet
Analysts How far the analysts' average target is from today's price.	3.5 / 10 No figures for this part: it counts as a cautious 35%.	—

Score capped at 60: free cash flow was negative in two of the last three years
Thin interest cover: operating profit is only -144.3× the interest
The last full year was a loss

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 85% of the figures (grade B). Warnings take 12 points off.

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.

Figures

Valuation
Figure	Value	Reading	Sector median
Price / book	-8.44×	Weak	3.8×
Price / sales	20.58×	Weak	3.19×
EV / EBITDA	-3.05×	Weak	12.61×
Free cash flow yield	-14.1%	Weak	2.5%

Quality
Figure	Value	Reading	Sector median
Gross margin	-83.3%	Weak	58.6%
Operating margin	-774.3%	Weak	7.6%
Net margin	0%	Weak	2.7%
Return on assets	-342.1%	Weak	3.5%

Growth
Figure	Value	Reading	Sector median
Revenue growth / year	5.6%	Fair	10.8%

Financial health
Figure	Value	Reading	Sector median
Debt / equity	-0.19×	Good	0.48×
Interest cover	-144.28×	Weak	2.65×
Current ratio	0.28×	Weak	2.36×

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Follow ONMD and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in